Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis

Abstract In recent years, both the number of patients with breast cancer and those with associated brain metastases (BMs) have increased. Human epidermal growth factor receptor 2 (HER2)-positive breast cancer has a high BM frequency. The prognosis of BM from breast cancer is poor, and establishing e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Case Reports in Oncology 2023-01, Vol.16 (1), p.497-502
Hauptverfasser:	Matsui, Chiaki, Shibata, Nobuhiro, Hirai, Chie, Tada, Manami, Kikawa, Yuichiro, Sugie, Tomoharu
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Antimitotic agents Antineoplastic agents Blindness Brain cancer brain metastases Breast cancer Cancer therapies Care and treatment Case Report Case reports Cerebrospinal fluid Cognitive ability Development and progression Drug dosages Drug therapy her2 Hydrocephalus Medical prognosis Metastasis Monoclonal antibodies Patients Prognosis Radiation Recovery (Medical) Response rates Targeted cancer therapy trastuzumab deruxtecan Tumors vision loss Visual acuity Visual impairment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!